binx health

binx health, based in Cambridge, Massachusetts, is a molecular diagnostics company founded in 2005. The company specializes in rapid, point-of-care testing solutions for sexually transmitted infections (STIs), including chlamydia and gonorrhea. Its primary product, the binx io, is an FDA-cleared, CLIA-waived molecular diagnostic platform that provides laboratory-quality PCR test results in approximately 30 minutes. This platform is suitable for various healthcare settings, such as doctors' offices, urgent care clinics, and retail pharmacies, facilitating a quick "test-and-treat" model to improve patient outcomes. In addition to its point-of-care offerings, binx health is developing mobile and digital health solutions for at-home testing, enhancing patient access to STI testing under physician supervision. The company has formed significant partnerships with major healthcare distributors, including Fisher Healthcare and McKesson, to support its market reach and manufacturing capabilities. With over $250 million raised in funding, binx health is committed to redefining convenient, evidence-based care for routine sexual health testing.

• Employees 90
• Founded 2005
• Annual Revenue $8000000
• Total Funding $279132600